NTI | bio (Nuclear Threat Initiative)
SIRDA Overview
SIRDA editorial content. This researched account is not written or approved by NTI | bio (Nuclear Threat Initiative). Published positions are summarized from public sources.
organization · Nonprofit / NGO · listed
- Name
- NTI | bio (Nuclear Threat Initiative)
- Profile slug
- nti-bio
- Version
- 1
- Focus areas
- Physical world: Biosecurity
- Founded
- Not recorded
- Headquarters
- Not recorded
- Website
- https://www.nti.org/area/biological/
- Leadership: public roles
- Not recorded
What they do
SIRDA editorial
At a glance
The biosecurity program of the Nuclear Threat Initiative, working to reduce catastrophic biological risks as bioscience and biotechnology advance. In 2024 it launched IBBIS and an international Common Mechanism for screening DNA synthesis orders, after incubating both from 2019.
Its current place in the ecosystem is Physical world: Biosecurity.
Current work and relevance
SIRDA has not yet completed dedicated research into NTI | bio (Nuclear Threat Initiative)'s current work beyond what is summarized above; this section is marked research-needed and will be revised as sourced findings become available.
DNA synthesis is a physical chokepoint where access is conditioned on screening. It is the closest working precedent for the access power discussed in the questions on actors who never joined and on cartel power.
Sources
Editorial note
This is SIRDA editorial content. Inclusion is an educational listing. It does not mean the subject has joined SIRDA, endorsed the founding inquiry, or approved this description. Factual corrections can be incorporated with a visible revision record, and substantive disagreements can be published as attributed responses.
Stated expertise
Expertise the organization has stated in its own published material, not a SIRDA ranking.
No stated expertise recorded.
Key work
No key work recorded.
Sources
Version history
House capitalization in displayed editorial summaries is standardized; stored historical versions are unchanged.
Version 1: Published SIRDA editorial snapshot: 2026-09-26 00:00:00+00
organization · Nonprofit / NGO · listed
- Name
- NTI | bio (Nuclear Threat Initiative)
- Profile slug
- nti-bio
- Version
- 1
- Focus areas
- Physical world: Biosecurity
- Founded
- Not recorded
- Headquarters
- Not recorded
- Website
- https://www.nti.org/area/biological/
- Leadership: public roles
- Not recorded
What they do
SIRDA editorial
At a glance
The biosecurity program of the Nuclear Threat Initiative, working to reduce catastrophic biological risks as bioscience and biotechnology advance. In 2024 it launched IBBIS and an international Common Mechanism for screening DNA synthesis orders, after incubating both from 2019.
Its current place in the ecosystem is Physical world: Biosecurity.
Current work and relevance
SIRDA has not yet completed dedicated research into NTI | bio (Nuclear Threat Initiative)'s current work beyond what is summarized above; this section is marked research-needed and will be revised as sourced findings become available.
DNA synthesis is a physical chokepoint where access is conditioned on screening. It is the closest working precedent for the access power discussed in the questions on actors who never joined and on cartel power.
Sources
Editorial note
This is SIRDA editorial content. Inclusion is an educational listing. It does not mean the subject has joined SIRDA, endorsed the founding inquiry, or approved this description. Factual corrections can be incorporated with a visible revision record, and substantive disagreements can be published as attributed responses.
Stated expertise
Expertise the organization has stated in its own published material, not a SIRDA ranking.
No stated expertise recorded.
Key work
No key work recorded.
Sources
Official Profile
This profile has not yet been claimed. SIRDA has created an educational listing for NTI | bio (Nuclear Threat Initiative) and invites an authorized representative to provide their own account.
Listed for educational purposes. Listing does not imply Alliance membership or endorsement. Correction submissions are not yet available.